OUTLOOK THERAPEUTICS INC (OTLK)

US69012T3059 - Common Stock

2.17  -0.01 (-0.46%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
3.812M
27.92%
3.088M
-18.99%
8.146M
163.83%
132.6K
-100.00%
307.02K7.25M76.837M
959.82%
199.96M
160.24%
438.72M
119.40%
388.36M
-11.48%
630.84M
62.44%
659.94M
4.61%
EBITDA
YoY % growth
-33.188M
32.20%
-26.59M
19.88%
-21.667M
18.51%
N/A
-65.04%
N/A
-43.92%
N/A
-22.15%
N/A
15.56%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-35.88M
30.12%
-29.644M
17.38%
-25.029M
15.57%
-38.371M
-45.08%
-49.518M
-42.45%
-66.098M
-21.93%
-57.308M
15.77%
-70.282M
-32.29%
-67.309M
4.23%
-9.343M
86.12%
129.64M
1,487.53%
306.64M
136.53%
239.92M
-21.76%
448.21M
86.82%
528.16M
17.84%
Operating Margin
-941.37%-960.11%-307.25%-28,937.69%-16,128.57%N/AN/AN/A-928.41%-12.16%64.83%69.89%61.78%71.05%80.03%
EPS
YoY % growth
-265.60
30.60%
N/A-1.22-9.79
-965.57%
-6.73
43.08%
-6.36
14.86%
-5.00
23.81%
-4.48
6.67%
-2.51
44.08%
-0.42
83.31%
1.19
385.37%
3.20
168.38%
5.21
62.74%
7.25
39.14%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.87
13.04%
-0.90
-12.97%
-0.72
53.41%
-0.57
31.92%
-0.42
51.91%
Revenue
Q2Q % growth
716.652K2.293M6.372M
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-20.493M
-64.48%
-20.834M
-101.81%
-18.285M
3.46%
-17.116M
12.51%
-14.45M
29.49%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.83
48.13%
-1.020.1918.46%
Q2 2024
Q2Q % growth
-1.55
-158.33%
-0.87-0.68-78.78%
Q1 2024
Q2Q % growth
-0.80
50.00%
-1.020.2221.57%
Q4 2023
Q2Q % growth
-1.00
23.08%
-1.200.2016.56%
Q3 2023
Q2Q % growth
-1.60 -1.05-0.55-52.50%
Q2 2023
Q2Q % growth
-0.60
66.67%
-1.330.7354.75%
Q1 2023
Q2Q % growth
-1.60 -1.07-0.53-49.39%
Q4 2022
Q2Q % growth
-1.30
27.78%
-1.380.085.59%
Q3 2022
Q2Q % growth
-1.60
-14.29%
-1.53-0.07-4.58%
Q2 2022
Q2Q % growth
-1.80 -1.29-0.51-39.33%
Q1 2022
Q2Q % growth
-1.60
33.33%
-1.22-0.38-30.72%
Q4 2021
Q2Q % growth
-1.80
30.77%
-1.22-0.58-47.06%
Q3 2021
Q2Q % growth
-1.40
36.36%
-1.500.106.41%
Q2 2021
Q2Q % growth
-1.80
30.77%
-1.63-0.17-10.29%
Q1 2021
Q2Q % growth
-2.40
57.14%
-1.63-0.77-47.06%
Q4 2020
Q2Q % growth
-2.60
-8.33%
-1.63-0.97-59.31%
Q3 2020
Q2Q % growth
-2.20
54.17%
-2.240.041.96%
Q2 2020
Q2Q % growth
-2.60
77.59%
-3.160.5617.77%
Q1 2020
Q2Q % growth
-5.60
-865.52%
-5.03-0.57-11.29%
Q4 2019
Q2Q % growth
-2.40 -6.263.8661.64%
Q3 2019
Q2Q % growth
-4.80 -7.412.6135.24%
Q2 2019
Q2Q % growth
-11.60 -13.461.8613.84%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
179.775K-179.775K-100.00%
Q4 2021
Q2Q % growth
306K-306K-100.00%
Q3 2021
Q2Q % growth
331.5K-331.5K-100.00%
Q2 2021
Q2Q % growth
331.5K-331.5K-100.00%
Q4 2020
Q2Q % growth

-100.00%
132.6K-132.6K-100.00%
Q3 2020
Q2Q % growth

-100.00%
165.75K-165.75K-100.00%
Q2 2020
Q2Q % growth

-100.00%
132.6K-132.6K-100.00%
Q1 2020
Q2Q % growth

-100.00%
446.25K-446.25K-100.00%
Q4 2019
Q2Q % growth
5.854M 624.75K5.229M836.93%
Q3 2019
Q2Q % growth
583.9K 637.5K-53.6K-8.41%
Q2 2019
Q2Q % growth
641.1K 765K-123.9K-16.20%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 14.05% 14.22%
RevenueN/A N/A N/A N/A